XBiotech (XBIT) Tax Provisions (2019 - 2026)
XBiotech (XBIT) posted Tax Provisions of $46000.0 for Q2 2026, down 39.47% on a QoQ basis from $76000.0 in Q4 2025, and up 64.29% year-over-year from $28000.0 in Q2 2025.
Powered by 
Analysis
XBiotech (XBIT) Tax Provisions (2019 - 2026) Analysis & Trends
XBiotech has reported Tax Provisions for 8 years, with the latest figure at $46000.0 in Q2 2026.
- On a quarterly basis, Tax Provisions rose 64.29% year-over-year to $46000.0 in Q2 2026; TTM through Jun 2026 was $252000.0, a 908.0% increase from a year earlier, with the FY2025 full-year figure at $235000.0, up 834.38% from the prior year.
- Tax Provisions was $46000.0 for Q2 2026 at XBiotech, down from $76000.0 in the prior quarter.
- The five-year high for Tax Provisions was $2.4 million in Q3 2022, with the low at -$2.6 million in Q2 2022.
- Average Tax Provisions over 5 years is -$3705.9, with a median of $29000.0 recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions plunged 135.21% in 2024, then soared 1033.33% in 2025.
- Over 5 years, Tax Provisions stood at $578000.0 in 2022, then plunged by 106.92% to -$40000.0 in 2023, then slipped by 2.5% to -$41000.0 in 2024, then jumped by 285.37% to $76000.0 in 2025, then sank by 39.47% to $46000.0 in 2026.
- The last three Tax Provisions figures came in at $46000.0 (Q2 2026), $76000.0 (Q4 2025), and $102000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 393.00 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 242.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 292.00 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 230.90 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | -59.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 15.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 34.90 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -3.96 Mn |
| 10 | XBiotech | 66.16 Mn | 66.16 Mn | - | 46,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46,000.00 |
| Dec 31, 2025 | 76,000.00 |
| Sep 30, 2025 | 102,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | -41,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | -25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | -40,000.00 |
| Sep 30, 2023 | 308,000.00 |
| Jun 30, 2023 | 71,000.00 |
| Mar 31, 2023 | 37,000.00 |
| Dec 31, 2022 | 578,000.00 |
| Sep 30, 2022 | 2.40 Mn |
| Jun 30, 2022 | -2.61 Mn |
| Mar 31, 2022 | -1.06 Mn |
| Dec 31, 2021 | -2.61 Mn |
| Sep 30, 2021 | -1.79 Mn |
| Jun 30, 2021 | -4.57 Mn |